Nocturnal systolic and diastolic blood pressure across gestational periods and the risk of preeclampsia
- PMID: 40634516
- DOI: 10.1038/s41371-025-01046-0
Nocturnal systolic and diastolic blood pressure across gestational periods and the risk of preeclampsia
Abstract
To investigate the relationship between blood pressure (BP) components (daytime vs. nocturnal BP and systolic vs. diastolic BP) and preeclampsia (PE) across gestational stages. We conducted a historical cohort study involving 1363 high-risk pregnant women (mean age, 30 ± 7 years). Ambulatory BP monitoring (ABPM) was performed at 12-19 weeks (n = 389), 20-27 weeks (n = 798), and 28-36 weeks (n = 1176); 59.9, 25.0, and 15.1% of the participants underwent one, two, and three ABPM evaluations, respectively. PE occurred in 15.4, 18.9, and 20.2% of the women evaluated at 12-19, 20-27, and 28-36 weeks, respectively. In the second half of pregnancy, sustained (daytime and nighttime) and isolated nocturnal hypertension were strong predictors of PE. Conversely, before the 20th week of gestation, only sustained hypertension (but not isolated nocturnal hypertension) increased PE risk, with lower odds ratios (ORs). Moreover, the areas under the curve (AUCs) for all ABPM components increased markedly after the 20th week of gestation. In late pregnancy, systolic and diastolic ABPM levels as well as all forms of nocturnal hypertension (isolated systolic, isolated diastolic, and combined systodiastolic) were significantly associated with PE risk, with ORs remaining significant after adjusting for daytime ABPM and maternal covariates. Patients with systodiastolic nocturnal hypertension had the highest risk. Conversely, neither daytime hypertension nor daytime ABPM levels remained statistically significant after adjusting for nocturnal ABPM levels. In conclusion, the association between PE and systolic, diastolic, and systodiastolic nocturnal hypertension emerges in the second half of pregnancy, suggesting a relationship with abnormal placentation.
© 2025. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Ethical approval: The CMDU protocol for ABPM evaluation during pregnancy was approved by the Medical Bioethics Committee of the Faculty of Medical Sciences, National University of La Plata (UNLP), Buenos Aires, Argentina (COBIMED 0/27). This observational study posed no risk to participants and was conducted in accordance with the Declaration of Helsinki. Conflict of interest: The authors declare that they have no affiliations with or involvement in any organization or entity with any financial interest in the subject matter or materials discussed in this manuscript.
Similar articles
-
Differences between office, home, and 24-hour ambulatory blood pressure monitoring in pregnant women with preeclampsia and uncomplicated hypertension.Pol Arch Intern Med. 2025 Aug 26;135(7-8):17052. doi: 10.20452/pamw.17052. Epub 2025 Jun 30. Pol Arch Intern Med. 2025. PMID: 40590313
-
The 2017 American College of Cardiology and American Heart Association blood pressure categories in the second half of pregnancy-a systematic review of their association with adverse pregnancy outcomes.Am J Obstet Gynecol. 2023 Aug;229(2):101-117. doi: 10.1016/j.ajog.2023.01.013. Epub 2023 Jan 16. Am J Obstet Gynecol. 2023. PMID: 36657559
-
Maternal vascular indices at 36 weeks' gestation in the prediction of preeclampsia.Am J Obstet Gynecol. 2024 Apr;230(4):448.e1-448.e15. doi: 10.1016/j.ajog.2023.09.095. Epub 2023 Sep 29. Am J Obstet Gynecol. 2024. PMID: 37778678
-
Relationship between serum uric acid, nocturnal hypertension and risk for preeclampsia in high-risk pregnancies.J Hum Hypertens. 2024 Sep;38(9):642-648. doi: 10.1038/s41371-024-00939-w. Epub 2024 Jul 23. J Hum Hypertens. 2024. PMID: 39043990
-
Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis.Am J Obstet Gynecol. 2023 Sep;229(3):222-247. doi: 10.1016/j.ajog.2023.03.032. Epub 2023 Mar 28. Am J Obstet Gynecol. 2023. PMID: 36990308
References
-
- Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 International Society for the study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148–69. - PubMed
-
- Salazar MR, Espeche WG, Leiva Sisnieguez BC, Balbín E, Leiva Sisnieguez CE, Stavile RN, et al. Significance of masked and nocturnal hypertension in normotensive women coursing a high-risk pregnancy. J Hypertens. 2016;34:2248–52. - PubMed
-
- Salazar MR, Espeche WG, Leiva Sisnieguez CE, Juliano PL, Vulcano MV, Sanchez Caro L, et al. Masked hypertension and neonatal outcome in high-risk pregnancies. J Hum Hypertens. 2023;37:36–41. - PubMed
-
- Scott G, Gillon TE, Pels A, von Dadelszen P, Magee LA. Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension. Am J Obstet Gynecol. 2022;226:S1222–36. - PubMed
-
- Sugulle M, Fiskå BS, Jacobsen DP, Fjeldstad HE, Staff AC. Placental senescence and the two-stage model of preeclampsia. Am J Reprod Immunol. 2024;92:e13904. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources